EVH stock forecast
Our latest prediction for Evolent Health, Inc.'s stock price was made on the Dec. 3, 2019 when the stock price was at 6.49$.
In the short term (2weeks), EVH's stock price should underperform the market by -4.62%. During that period the price should oscillate between -9.90% and +11.53%.
In the medium term (3months), EVH's stock price should underperform the market by -12.20%. During that period the price should oscillate between -30.52% and +20.96%.Get email alerts
About Evolent Health, Inc.
Evolent Health, Inc. engages in the provision of health care delivery and payment services. Its solutions include population health management, health plan administration and third party administration, network performance management, risk adjustment, pharmacy benefit management, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services segment and True Health segment. The Services segment includes three types of services designed to help partners manage patient health; value-based care services, specialty care management services and comprehensive health plan administration services. The True Health segment, which operates a health plan in New Mexico, and provides reinsurance to NMHC, takes on certain insurance and underwriting costs in pricing its premiums. The company was founded by Frank J. Williams, Seth B. Blackley, and Tom Peterson in August 2011 and is headquartered in Arlington, VA.
At the moment the company generates 803M USD in revenues.
On its last earning announcement, the company reported a loss of -1.48$ per share.
The book value per share is 13.24$
Three months stock forecastDec. 3, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|